Rasch analysis of the Western Ontario Osteoarthritis of the Shoulder index – the Danish version

por Moeini, Sahar, Rasmussen, Jeppe V, Klausen, Tobias W, Brorson, Stig
Publicado 2016

Circadian rhythm of markers of bone turnover in patients with chronic kidney disease

por Hansen, D., Bressendorff, I., Nordholm, A., Jacobsen, A.A., Klausen, T.W., Jørgensen, N.R.
Publicado 2022

Increased use of total shoulder arthroplasty for osteoarthritis and improved patient-reported outcome in Denmark, 2006–2015: a nationwide cohort study from the Danish Shoulder Arth...

por Rasmussen, Jeppe V, Amundsen, Alexander, Sørensen, Anne Kathrine B, Klausen, Tobias W, Jakobsen, John, Jensen, Steen L, Olsen, Bo S
Publicado 2019

Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease

por Jacobsen, Alexanndra A., Bressendorff, Iain, Nordholm, Anders, Egstrand, Søren, Jørgensen, Niklas R., Klausen, Tobias W., Olgaard, Klaus, Hansen, Ditte
Publicado 2021

Double versus single high-dose melphalan 200 mg/m(2) and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area

por Björkstrand, Bo, Klausen, Tobias W., Remes, Kari, Gruber, Astrid, Knudsen, Lene M., Bergmann, Olav J., Lenhoff, Stig, Johnsen, Hans E.
Publicado 2009

No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma

por Vangsted, Annette J, Søeby, Karen, Klausen, Tobias W, Abildgaard, Niels, Andersen, Niels F, Gimsing, Peter, Gregersen, Henrik, Vogel, Ulla, Werge, Thomas, Rasmussen, Henrik B
Publicado 2010

Improved survival in myeloma patients–a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden

por Moore, Kari Lenita Falck, Turesson, Ingemar, Genell, Anna, Klausen, Tobias W., Knut-Bojanowska, Dorota, Redder, Louise, Sverrisdottir, Ingigerdur, Thorsen, Jonathan, Vangsted, Annette J., Blimark, Cecilie H.
Publicado 2022

Salvage bortezomib–dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial

por Gimsing, P, Hjertner, Ø, Abildgaard, N, Andersen, N F, Dahl, T G, Gregersen, H, Klausen, T W, Mellqvist, U-H, Linder, O, Lindås, R, Tøffner Clausen, N, Lenhoff, S
Publicado 2015

Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population

por Sørrig, Rasmus, Klausen, Tobias W., Salomo, Morten, Vangsted, Annette J., Frølund, Ulf Christian, Andersen, Kristian T., Klostergaard, Anja, Helleberg, Carsten, Pedersen, Robert S., Pedersen, Per T., Helm-Petersen, Sissel, Teodorescu, Elena Manuela, Preiss, Birgitte, Abildgaard, Niels, Gimsing, Peter
Publicado 2017

Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial

por Sivapalan, Pradeesh, Jørgensen, Niklas R., Mathioudakis, Alexander G., Eklöf, Josefin, Lapperre, Therese, Ulrik, Charlotte Suppli, Andreassen, Helle F., Armbruster, Karin, Sivapalan, Praleene, Janner, Julie, Godtfredsen, Nina, Weinreich, Ulla M., Nielsen, Thyge L., Seersholm, Niels, Wilcke, Torgny, Schuetz, Philipp, Klausen, Tobias W., Marså, Kristoffer, Vestbo, Jørgen, Jensen, Jens-Ulrik
Publicado 2020